Skip to main
HR

HR Stock Forecast & Price Target

HR Analyst Ratings

Based on 9 analyst ratings
Hold
Strong Buy 11%
Buy 22%
Hold 67%
Sell 0%
Strong Sell 0%

Bulls say

Healthcare Realty Trust Inc. exhibits a strong financial trajectory, with a reported same-store NOI growth forecast of 5.5% for 4Q25 and 4.8% for FY2025, supported by an occupancy improvement to 92.1% by year-end. The company's strategic initiatives, including a $10 million review, have sparked increased interest in specific assets, indicating a strengthening position within the healthcare real estate market. Furthermore, Healthcare Realty Trust's execution of a 5.4x levered balance sheet by 4Q25 suggests effective management and enhanced risk-adjusted returns through long-term leases and mortgages, contributing to a positive outlook for the stock.

Bears say

Healthcare Realty Trust Inc. faces a challenging financial outlook, marked by a 6% decline in its IFRS NAVPU to $17.74, indicating substantial downward pressure on its asset valuation. The company's forecasted funds from operations per unit (FFOPU) and adjusted funds from operations per unit (AFFOPU) for 2027 are projected to be 10%-20% below prior consensus estimates, reflecting anticipated declines of 4%-8% in compound annual growth rate (CAGR) during the period from 2025 to 2027. Furthermore, recurring FFOPU reported a quarter-over-quarter decline of 4.4% and a year-over-year decrease of 1.5%, signaling weakening performance against both internal expectations and broader market consensus.

HR has been analyzed by 9 analysts, with a consensus rating of Hold. 11% of analysts recommend a Strong Buy, 22% recommend Buy, 67% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Healthcare Realty Trust Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Healthcare Realty Trust Inc (HR) Forecast

Analysts have given HR a Hold based on their latest research and market trends.

According to 9 analysts, HR has a Hold consensus rating as of Apr 23, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $18.78, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $18.78, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Healthcare Realty Trust Inc (HR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.